首页> 外文期刊>Current pharmaceutical design >Current Perspectives Regarding Stem Cell-based Therapy for Ischemic Stroke
【24h】

Current Perspectives Regarding Stem Cell-based Therapy for Ischemic Stroke

机译:关于缺血性卒中的干细胞疗法的目前的视角

获取原文
获取原文并翻译 | 示例
           

摘要

Stroke is a leading cause of death and disability worldwide. Conventional treatment has a limitation of very narrow therapeutic time window and its devastating nature necessitate a novel regenerative approach. Transplanted stem cells resulted in functional recovery through multiple mechanisms including neuroprotection, neurogenesis, angiogenesis, immunomodulation, and anti-inflammatory effects. Despite the promising features shown in experimental studies, results from clinical trials are inconclusive from the perspective of efficacy. The present review presents a synopsis of stem cell research on ischemic stroke treatment according to cell type. Clinical trials to the present are briefly summarized. Finally, the hurdles and issues to be solved are discussed for clinical application.
机译:中风是全世界死亡和残疾的主要原因。 常规处理具有非常窄的治疗时间窗口,其毁灭性是必要进行新的再生方法。 移植的干细胞通过包括神经保护,神经发生,血管生成,免疫调节和抗炎作用的多种机制导致功能恢复。 尽管实验研究中所示的有希望的特征,但临床试验的结果是从功效的角度不确定。 本综述提出了根据细胞类型的缺血性卒中治疗干细胞研究的概要。 简要概述了目前的临床试验。 最后,讨论了临床应用的障碍和问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号